These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35340932)

  • 21. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
    Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
    Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
    Chakravarty PK; Carl PL; Weber MJ; Katzenellenbogen JA
    J Med Chem; 1983 May; 26(5):633-8. PubMed ID: 6221099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450-based cancer gene therapy: recent advances and future prospects.
    Waxman DJ; Chen L; Hecht JE; Jounaidi Y
    Drug Metab Rev; 1999 May; 31(2):503-22. PubMed ID: 10335450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives.
    Dhankhar R; Kawatra A; Mohanty A; Gulati P
    Curr Protein Pept Sci; 2021; 22(7):514-525. PubMed ID: 33290198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy.
    El-Sayed ASA; Mohamed NZ; Yassin MA; Amer MM; El-Sharkawy R; El-Sayed N; Ali MG
    Heliyon; 2022 Sep; 8(9):e10660. PubMed ID: 36164544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice.
    Antoniw P; Springer CJ; Bagshawe KD; Searle F; Melton RG; Rogers GT; Burke PJ; Sherwood RF
    Br J Cancer; 1990 Dec; 62(6):909-14. PubMed ID: 2257218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development.
    Maslah H; Skarbek C; Gourson C; Plamont MA; Pethe S; Jullien L; Le Saux T; Labruère R
    Angew Chem Int Ed Engl; 2021 Nov; 60(45):24043-24047. PubMed ID: 34487611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
    Wallace PM; Senter PD
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems.
    Yao Q; Lin F; Fan X; Wang Y; Liu Y; Liu Z; Jiang X; Chen PR; Gao Y
    Nat Commun; 2018 Nov; 9(1):5032. PubMed ID: 30487642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted enzyme prodrug therapies.
    Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C
    Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhance the efficiency of 5-fluorouracil targeted delivery by using a prodrug approach as a novel strategy for prolonged circulation time and improved permeation.
    Pasban S; Raissi H; Pakdel M; Farzad F
    Int J Pharm; 2019 Sep; 568():118491. PubMed ID: 31276765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Cytotoxic Potentials of Some Isoindole-1, 3-Dione Derivatives on HeLa, C6 and A549 Cancer Cell Lines.
    Tan A; Yaglioglu AS; Kishali NH; Sahin E; Kara Y
    Med Chem; 2020; 16(1):69-77. PubMed ID: 30520382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L.
    Ueki N; Wang W; Swenson C; McNaughton C; Sampson NS; Hayman MJ
    Theranostics; 2016; 6(6):808-16. PubMed ID: 27162551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted prodrug approaches for hormone refractory prostate cancer.
    Aloysius H; Hu L
    Med Res Rev; 2015 May; 35(3):554-85. PubMed ID: 25529338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Application of Prodrug-based Drug Delivery Strategy in Anticancer Drugs.
    Liu N; Chen Q; Zhang Q; Wang J; Si R; Zhang J; Pan X
    Curr Top Med Chem; 2021; 21(24):2184-2204. PubMed ID: 34503405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.